Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3096759 Title: FORMULATIONS À LIBÉRATION MODIFIÉE DE PRIDOPIDINE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
157403031
WO application number:
US2015012248
Type:
European patent granted for BE
Status:
Open
Publication number:
3096759
WO publication number:
WO2015112601
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
21/01/2015
Grant date:
06/04/2022
EP publication date:
30/11/2016
WO publication date:
30/07/2015
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
06/04/2022
EP B1 publication date:
06/04/2022
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
21/01/2035

Applicant

Name:
Prilenia Neurotherapeutics Ltd.
Legal Form:
From:
06/04/2022
Address:
10 HaMenofim Street, Herzliya 4672561, Israel (IL)
To:

Agent

1

Name:
COSMOVICI Paul
Legal Form:
From:
20/12/2024
Address:
c/o Cosmovici Intellectual Property 15 Place Charles de Gaulle, Bâtiment Charles de Gaulle, 3e étage, District 1, 011886, Bucarest, Romania (RO)
To:

2

Name:
COSMOVICI Paul
Legal Form:
From:
25/10/2023
Address:
c/o Cosmovici Intellectual Property SàRL Boulevard du Régent 54, 1000, Bruxelles, Belgium (BE)
To:
08/04/2024

3

Name:
COSMOVICI Paul
Legal Form:
From:
13/04/2022
Address:
c/o Cosmovici Intellectual Property SàRL Rond-Point Schuman 6, Case 5, 1040, Bruxelles, Brussels, Belgium (BE)
To:
25/10/2023

4

Name:
COSMOVICI Paul
Legal Form:
From:
08/04/2024
Address:
c/o Cosmovici Intellectual Property SàRL, Unilever Belgium City Dox, Boulevard Industriel 9, 1070, Bruxelles, Belgium (BE)
To:
20/12/2024

Inventor

1

Name:
LICHT, Daniella
Legal Form:
Address:
Givat Shmuel, Israel (IL)

2

Name:
LOVINGER, Ioana
Legal Form:
Address:
4424541 Kfar Saba, Israel (IL)

3

Name:
GUILATT, Laura Yehudit
Legal Form:
Address:
60920 Kadima, Israel (IL)

4

Name:
BASSAN, Merav
Legal Form:
Address:
Ramat Gan 5253179, Israel (IL)

Priority

1

Priority patent number:
201462050626 P
Priority date:
15/09/2014
Priority country:
United States (US)

2

Priority patent number:
201461930358 P
Priority date:
22/01/2014
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 31/451; C07D 211/20; C07D 211/24; A61K 9/16; A61P 25/08; A61P 25/16; A61P 25/28;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2022/07
Publication date:
22/04/2022
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

1

Issue number:
202214
Publication date:
06/04/2022
Description:
Grant (B1)

2

Issue number:
202217
Publication date:
27/04/2022
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual fee

Annual fee(s) Due Date:
02/02/2026
Annual fee number:
12
Annual fee amount:
240 Euro
Expected payer:
Last annual fee payment date:
20/12/2024
Last annual fee paid number:
11
Last annual fee paid amount:
215 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
13/04/2022 Incoming Correspondence (Post) 1 PDF /6/1/4/4/1/0722214416/docs/157403031_0_incomingcorrespondencepaper_20220413_023304081.pdf
25/10/2023 Request For Change Letter and/or Form requesting a change in the Register 14 PDF /6/1/4/4/1/0722214416/docs/157403031_1_rfc_20231025_115616231.pdf
08/04/2024 Request For Change Letter and/or Form requesting a change in the Register 1 PDF /6/1/4/4/1/0722214416/docs/157403031_2_rfc_20240415_113247389.pdf
12/08/2024 Outgoing Correspondence Outgoing Correspondence 2 PDF /6/1/4/4/1/0722214416/docs/157403031_3_201332_pie.rfc.man.notif.pdf
08/04/2024 Incoming Correspondence (Post) 13 PDF /6/1/4/4/1/0722214416/docs/157403031_4_incomingcorrespondencepaper_20240415_113247407.pdf
20/12/2024 Request For Change Letter and/or Form requesting a change in the Register 49 PDF /6/1/4/4/1/0722214416/docs/157403031_5_rfc_20250106_120045098.pdf
28/01/2025 Outgoing Correspondence Outgoing Correspondence 2 PDF /6/1/4/4/1/0722214416/docs/157403031_6_209683_pie.rfc.per.notif.pdf
21/01/2025 Incoming Correspondence (Post) 51 PDF /6/1/4/4/1/0722214416/docs/157403031_7_incomingcorrespondencepaper_20250127_104154180.pdf